RAC nixes plan to treat retinoblastoma.
Garber
K
K
D026683:Advisory Committees; D002675:Child, Preschool; D002985:Clinical Protocols; D002986:Clinical Trials as Topic; D004274:DNA, Recombinant; D035082:Federal Government; D015316:Genetic Therapy / Q000009:adverse effects; D033161:Government Regulation; D006801:Humans; D007223:Infant; D009316:National Institutes of Health (U.S.); D011640:Public Policy; D019572:Retinal Neoplasms / Q000628:therapy*; D012175:Retinoblastoma / Q000628:therapy*; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration
D004274:DNA, Recombinant